Ledger.Open graph →
SEC Form D · filed May 3, 2016

Symbiomix Therapeutics, LLC

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWARK, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Rishi Gupta · Cambridge, MADirectorRobert Jacks · Newark, NJExecKaren Dawes · Newark, NJDirectorKlaus Veitinger · Newark, NJDirectorThomas Beck · Newark, NJDirectorSusan E. Hodgkinson · New York, NYDirectorClive J. Harris · Grand Cayman, Cayman IslandsDirectorDavid Crisalli · Paradise Valley, AZDirectorChristopher J. Kenny · Chicago, ILExecJoseph Amprey · Washington, Washington, D.C.ExecBen Auspitz · Bozeman, MTDirectorJ.D. T. Murphy · Bethesda, MDDirectorDaniel T. Thomas · Bethesda, MDExecTaylor J. Lauber · New York, NYDirectorMichael S. Weiss · New York, NYDirectorKaren Dawes · Palm Beach Gardens, FLDirectorJoseph Amprey · Newark, NJExecBen Auspitz · DURHAM, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗